Literature DB >> 30804112

β-Hydroxy-β-methylbutyrate Suppresses NF-ĸB Activation and IL-6 Production in TE-1 Cancer Cells.

Sachi Miyake1, Ayako Ogo2, Hisako Kubota3, Fusako Teramoto2, Toshihiro Hirai2.   

Abstract

BACKGROUND/AIM: Stress reactions, especially those related to surgery, cause poor convalescence of cancer patients. β-Hydroxyβ-methylbutyrate (HMB) is known to regulate excessive inflammation in the body. The objective of this work was to investigate the capacity of HMB to suppress activation of nuclear factor-kappa B (NF-ĸB) and production of interleukin-6 (IL-6) in a human esophageal squamous cell carcinoma cell line (TE-1).
MATERIALS AND METHODS: Cell proliferation was measured using the water-soluble tetrazolium-1 method, while tumor necrosis factor alpha (TNFα)-induced IL-6 production was measured using an enzyme-linked immunosorbent assay (ELISA) assay. Nuclear translocation of NF-ĸB was detected by immunofluorescence staining.
RESULTS: HMB did not affect cell proliferation. However, HMB suppressed the TNFα-induced increase in IL-6 production in TE-1 cells by inhibiting NF-ĸB activation.
CONCLUSION: HMB did not influence TE-1 cell proliferation, but inhibited activation of NF-ĸB and IL-6 production. This result may be useful for improving excessive stress reactions during and after surgery. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  NF-ĸB; TE-1 cells; β-Hydroxy-β-Methylbutyrate (HMB)

Mesh:

Substances:

Year:  2019        PMID: 30804112      PMCID: PMC6506311          DOI: 10.21873/invivo.11481

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  The Effects of β-Hydroxy-β-Methylbutyrate (HMB) on Chemotaxis, Phagocytosis, and Oxidative Burst of Peripheral Blood Granulocytes and Monocytes in Goats.

Authors:  Roman Wójcik; Katarzyna Ząbek; Joanna Małaczewska; Stanisław Milewski; Edyta Kaczorek-Łukowska
Journal:  Animals (Basel)       Date:  2019-11-26       Impact factor: 2.752

2.  The effects of preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine on inflammatory and hematological markers of patients with heart surgery: a randomized controlled trial.

Authors:  Mona Norouzi; Azadeh Nadjarzadeh; Majid Maleki; Sayyed Saeid Khayyatzadeh; Saeid Hosseini; Mehdi Yaseri; Hamed Fattahi
Journal:  BMC Surg       Date:  2022-02-11       Impact factor: 2.102

3.  Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia.

Authors:  Guanlin Xiao; Zhihao Zeng; Jieyi Jiang; Aili Xu; Sumei Li; Yangxue Li; Zhao Chen; Weitao Chen; Jingnian Zhang; Xiaoli Bi
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.